基本信息 产品详情 公司简介 推荐产品
网站主页 MRPL3 ANTIBODY MRPL3抗体
  • MRPL3抗体
  • MRPL3抗体
  • MRPL3抗体

1/3

MRPL3抗体

Rabbit Polyclonal MRPL3 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
MRPL3抗体
英文名称:
Rabbit Polyclonal MRPL3 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 4990 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
MRPL3

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesMRL3; RPML3; COXPD9
WB Predicted band size39 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human MRPL3
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-4: A549, Hela, HepG2, 293T cell lysates, Primary antibody: P09670(MRPL3 Antibody) at dilution 1/650, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P09670(MRPL3 Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于MRPL3抗体的3篇参考文献示例(注:文献为虚拟示例,实际引用需通过学术数据库核实):

---

1. **文献名称**:*MRPL3 is essential for mitochondrial ribosome assembly and respiratory chain function*

**作者**:Smith A, et al.

**摘要**:该研究通过CRISPR敲除MRPL3基因,发现其缺失导致线粒体核糖体大亚基组装缺陷,并显著降低呼吸链复合物活性。利用MRPL3抗体进行免疫印迹和免疫荧光,证实其在HeLa细胞线粒体中的定位,提示MRPL3对线粒体蛋白质合成的关键作用。

2. **文献名称**:*Overexpression of MRPL3 correlates with poor prognosis in hepatocellular carcinoma*

**作者**:Zhang Y, et al.

**摘要**:通过免疫组化(使用MRPL3抗体)分析肝癌组织样本,发现MRPL3在肿瘤组织中高表达,且与患者总生存期缩短相关。功能实验表明,抑制MRPL3可降低癌细胞增殖,提示其作为潜在治疗靶点。

3. **文献名称**:*A novel MRPL3 mutation causes mitochondrial encephalomyopathy in humans*

**作者**:Lee S, et al.

**摘要**:研究报道一例由MRPL3基因错义突变引起的线粒体脑肌病病例。通过Western blot(使用MRPL3抗体)发现患者成纤维细胞中MRPL3蛋白水平显著下降,导致线粒体翻译缺陷和ATP合成减少,为疾病机制提供分子证据。

---

**提示**:实际研究中,建议通过PubMed或Google Scholar以“MRPL3 antibody”或“MRPL3 mitochondrial ribosome”为关键词检索最新文献,并优先选择近5年、高影响因子期刊的研究。

       

背景信息

The MRPL3 (Mitochondrial Ribosomal Protein L3) antibody is a valuable tool in studying mitochondrial protein synthesis and its associated cellular processes. MRPL3 is a core component of the large subunit of the mitochondrial ribosome, essential for mitochondrial translation machinery. Mitochondria, the energy-producing organelles, rely on their own ribosomes to synthesize subunits of the electron transport chain (ETC) complexes, which are critical for oxidative phosphorylation. MRPL3 plays a structural and functional role in assembling the mitochondrial ribosome, ensuring proper ETC complex formation and cellular energy homeostasis.

Antibodies targeting MRPL3 are widely used to investigate mitochondrial ribosome biogenesis, protein expression levels, and subcellular localization via techniques like Western blotting, immunofluorescence, and immunohistochemistry. Research involving MRPL3 has linked its dysregulation to mitochondrial disorders, metabolic diseases, and cancer, as disrupted mitochondrial translation can impair energy production and promote tumorigenesis. Studies also explore MRPL3’s role in apoptosis, aging, and neurodegenerative diseases like Parkinson’s, where mitochondrial dysfunction is a hallmark.

Commercial MRPL3 antibodies are typically raised against specific epitopes of human MRPL3. with cross-reactivity tested in common model organisms. Validated antibodies aid in distinguishing mitochondrial vs. cytosolic ribosomal proteins, providing insights into organelle-specific translation mechanisms. As mitochondrial research expands, MRPL3 antibodies remain critical for unraveling the molecular basis of diseases tied to energy metabolism and cellular stress responses.

       
MRPL3抗体;MRPL3;MRPL3 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

MRPL3抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价